ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Edward Harlow Named Recipient Of Bristol Award

March 29, 1991

The Cancer Letter Stands By Story

October 30, 1998

National Cancer Policy Board will end in 2005, NCI to support a cancer forum at IOM.

November 5, 2004

NCA Approves Major Revision In Program Project Guidelines; Smaller, Tightly Focused Grants Seen

May 27, 1983

PHS Plans Revitalization of Commissioned Corps

July 11, 2003

Conference Split Difference, NCI Gets $1.075 Billion

October 21, 1983